This COVID-19 vaccine linked to lower risk for clotting, blockages
By
Kristen Fischer
Aug 04, 2023
A study that put both COVID-19 shots to the test to see which was better for older adults found that the Moderna vaccine was superior.
Clinical briefs for Thursday, Nov. 17
By
Alicia Lasek
Nov 17, 2022
New data suggest Moderna’s updated COVID booster is more effective against omicron variants … Slightly faster cognitive decline after knee replacement found in people aged 80 and older … Careful...
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.
Moderna vaccine better at protecting long-term care residents: study
By
Danielle Brown
Jul 28, 2022
Long-term care leaders helping residents secure COVID-19 vaccinations may want to ensure their pharmacy provider has Moderna vaccines on hand after a study found that it was better at protecting residents...
Clinical briefs for Thursday, June 9
By
Alicia Lasek (f3)
Jun 09, 2022
Moderna’s omicron-targeting vaccine provides improved protection, company says … Evusheld found to protect against COVID-19 death in late-stage trial … … FTC to probe pharmacy middlemen’s role...
Clinical briefs for Thursday, Feb. 24
By
Alicia Lasek
Feb 24, 2022
12 women named Veteran VIPs in McKnight’s Women of Distinction Awards … 3 Moderna shots offer 99% protection against omicron, delta hospitalization … COVID-19 infections fall by 90% from pandemic...
Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
By
Alicia Lasek
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Shot targeting omicron may be ready by March, Pfizer predicts
By
Alicia Lasek
Jan 11, 2022
The company says it is working with partner BioNTech to develop a shot that will combine its original vaccine with a drug that helps build immunity to the highly transmissible omicron variant.
Clinical briefs for Monday, Jan. 10
By
Alicia Lasek
Jan 10, 2022
Supreme Court grills attorneys over worker COVID-19 vaccination mandates … FDA shortens booster interval for Moderna vaccine to five months … Dementia prevalence estimated to increase to 152 million...